Delivery Order SPE2DB22D3004-SPE2DB25FPV72

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,917.30 firm fixed-price delivery order is for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has a 2-year period of performance ending on December 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,143.06 firm fixed price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,741.16, is for the supply of the pharmaceutical product FERUMOXYTOL 510 MG/17 ML VIAL 17ML. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.75 firm fixed-price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials. The contract has a period of performance through July 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,717.30, is for the delivery of ferumoxytol 510 mg/17 ml vials. It is a firm fixed-price contract with a period of performance through March 11, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,905.78, is for the delivery of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. It is not associated with a set-aside requirement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ferumoxytol 510 mg/17 ml vials. The total ceiling value of the order is $11,582.66, with a firm fixed-price contract type and an ultimate completion date of May 9, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract has a firm fixed price, with a ceiling value of $8,423.11, and a completion date of October 10, 2024. This contract is not designated as a set-aside. AmerisourceBergen, through its Corporate Office division, has been awarded multiple federal contracts and indefinite delivery contracts...
This federal contract award, valued at $1,282.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of ferumoxytol, a 510 mg/17 ml vial medication, with a completion date of September 25, 2024. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPV72
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,511.22, for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of March 11, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award reviewed has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award does not mention any major subcontractors.

Generated 6/9/25, 9:59 AM